House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government what steps they are taking (1) to address the efficacy of the 12 week gap between doses of the COVID-19 vaccine for blood cancer patients, and (2) to protect such patients who have received one dose of a COVID-19 vaccine from exposure to COVID-19.  HL14925

Question HL14925: tabled on 14 April 2021 and due for answer by 28 April 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government what steps they are taking (1) to address the efficacy of the 12 week gap between doses of the COVID-19 vaccine for blood cancer patients, and (2) to protect such patients who have received one dose of a COVID-19 vaccine from exposure to COVID-19.  HL14925
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer